Price T Rowe Associates Inc Corcept Therapeutics Inc Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 52,928 shares of CORT stock, worth $3.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,928
Previous 51,135 3.51%
Holding current value
$3.12 Million
Previous $1.66 Million 47.41%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $52,911 - $82,944
1,793 Added 3.51%
52,928 $2.45 Million
Q2 2024

Aug 14, 2024
BUY
$22.21 - $34.48 $60,166 - $93,406
2,709 Added 5.59%
51,135 $1.66 Million
Q1 2024

May 15, 2024
SELL
$21.1 - $27.46 $65,599 - $85,373
-3,109 Reduced 6.03%
48,426 $1.22 Million
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $70,737 - $93,708
2,850 Added 5.85%
51,535 $1.67 Million
Q3 2023

Nov 14, 2023
BUY
$21.97 - $33.8 $44,862 - $69,019
2,042 Added 4.38%
48,685 $1.33 Million
Q2 2023

Aug 14, 2023
BUY
$21.44 - $25.15 $17,838 - $20,924
832 Added 1.82%
46,643 $1.04 Million
Q1 2023

May 15, 2023
BUY
$19.2 - $24.47 $42,259 - $53,858
2,201 Added 5.05%
45,811 $993,000
Q4 2022

Feb 14, 2023
BUY
$19.95 - $29.96 $41,535 - $62,376
2,082 Added 5.01%
43,610 $886,000
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $141,555 - $166,886
5,731 Added 16.01%
41,528 $1.07 Million
Q2 2022

Aug 15, 2022
BUY
$17.33 - $25.3 $125,295 - $182,919
7,230 Added 25.31%
35,797 $851,000
Q1 2022

May 16, 2022
BUY
$16.53 - $25.21 $66,615 - $101,596
4,030 Added 16.42%
28,567 $643,000
Q4 2021

Feb 14, 2022
SELL
$17.1 - $23.34 $311,664 - $425,394
-18,226 Reduced 42.62%
24,537 $486,000
Q3 2021

Nov 15, 2021
BUY
$19.68 - $22.53 $3,936 - $4,506
200 Added 0.47%
42,763 $842,000
Q2 2021

Aug 16, 2021
BUY
$19.97 - $24.43 $31,173 - $38,135
1,561 Added 3.81%
42,563 $936,000
Q1 2021

May 17, 2021
SELL
$23.49 - $30.56 $3,171 - $4,125
-135 Reduced 0.33%
41,002 $975,000
Q4 2020

Feb 16, 2021
BUY
$16.78 - $27.3 $690,278 - $1.12 Million
41,137 New
41,137 $1.08 Million

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.32B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email